Form4insider filings, from the source

SEC Form 4 · accession 0001103780-15-000035

Lexaria Bioscience Corp. · LXRP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Christopher Bunka
Officer — CEO · Director · 10% Owner
Period of report
Jan 20, 2010
Accepted (ET)
Jul 24, 2015 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common SharesJul 23, 2015P27,550$0.139A4,634,230D
Common SharesJul 23, 2015P10,000$0.14A4,644,230D
Common SharesJul 24, 2015P10,000$0.155A4,654,230D
Common SharesJul 24, 2015P25,000$0.15A4,679,230D
Common SharesJul 24, 2015P20,000$0.1499A4,699,230D
Common SharesJul 24, 2015P5,000$0.1499A4,704,230D
Common SharesJul 24, 2015P10,000$0.1499A4,714,230D
Common SharesJul 24, 2015P5,000$0.1499A4,719,230D
Common SharesJul 24, 2015P5,000$0.1499A4,724,230D
Common SharesJul 24, 2015P5,000$0.1499A4,729,230D
Common SharesJul 24, 2015P20,000$0.15A4,749,230D
Common Sharesholding———4,488,958IPrivate Holding Company
Common Sharesholding———4,606,680D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Options$0.11holding———Dec 23, 2014Dec 23, 2019Common Shares500,000500,000D
Stock Options$0.35holding———Jul 11, 2011Jul 11, 2016Common Shares200,000700,000D
Stock Options$0.10holding———Jun 18, 2013Jun 18, 2018Common Shares225,000925,000D
Warrants$0.25holding———Mar 21, 2014Sep 21, 2015Common Shares100,0671,025,067D
Warrants$0.25holding———May 15, 2015May 15, 2017Common Shares170,000170,000I